Table 2 Differential Ca-ion/control adsorbed protein ratio. Data with ANOVA p < 0.05 and a ratio higher than 1.5 in either direction was considered as significantly different
From: Influence of calcium ion-modified implant surfaces in protein adsorption and implant integration
Accession | Description | p value | Ratio |
|---|---|---|---|
FA10_HUMAN | Coagulation factor X | 1.13E−04 | 181.42 |
LYSC_HUMAN | Lysozyme C | 2.29E−02 | 13.60 |
PIP_HUMAN | Prolactin-inducible protein | 3.90E−02 | 2.98 |
SAMP_HUMAN | Serum amyloid P-component | 4.66E−02 | 2.59 |
A1AT_HUMAN | Alpha-1-antitrypsin | 3.97E−03 | 0.53 |
TRFE_HUMAN | Serotransferrin | 1.69E−02 | 0.46 |
VTNC_HUMAN | Vitronectin | 2.13E−02 | 0.45 |
APOE_HUMAN | Apolipoprotein E | 4.78E−03 | 0.41 |
SAA4_HUMAN | Serum amyloid A-4 protein | 3.45E−02 | 0.38 |
PLMN_HUMAN | Plasminogen | 1.10E−02 | 0.28 |
FA12_HUMAN | Coagulation factor XII | 4.26E−02 | 0.26 |
KNG1_HUMAN | Kininogen-1 | 1.16E−04 | 0.24 |
ATPA_HUMAN | ATP synthase subunit alpha mitochondrial | 3.56E−02 | 0.24 |
ACTBL_HUMAN | Beta-actin-like protein 2 | 3.65E−02 | 0.19 |
DHX8_HUMAN | ATP-dependent RNA helicase DHX8 | 4.11E−02 | 0.13 |
HEP2_HUMAN | Heparin cofactor 2 | 4.92E−02 | 0.13 |
CFAH_HUMAN | Complement factor H | 1.28E−02 | 0.06 |